Skip to content
Home » News » Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack

Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack

  • by

Scientists at Johns Hopkins say that an experimental antibody drug appears to prevent and reverse the onset of type 1 diabetes in mice—and often lengthen their lives. The drug called mAb43 is unique, according to the researchers, because it targets insulin-making beta cells in the pancreas directly and is designed to shield those cells from […]

The post Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack appeared first on Good News Network.

Leave a Reply

Your email address will not be published. Required fields are marked *